- Home
- BHAT vs APVO Comparison
BHAT vs APVO Comparison
Compare BHAT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- APVO
- Stock Information
- Founded
- BHAT 2010
- APVO 2016
- Country
- BHAT China
- APVO United States
- Employees
- BHAT N/A
- APVO N/A
- Industry
- BHAT Recreational Games/Products/Toys
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- APVO Health Care
- Exchange
- BHAT Nasdaq
- APVO Nasdaq
- Market Cap
- BHAT 10.3M
- APVO 4.1M
- IPO Year
- BHAT 2019
- APVO N/A
- Fundamental
- Price
- BHAT $1.85
- APVO $3.00
- Analyst Decision
- BHAT
- APVO Strong Buy
- Analyst Count
- BHAT 0
- APVO 1
- Target Price
- BHAT N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- BHAT 98.2K
- APVO 6.7M
- Earning Date
- BHAT 04-30-2025
- APVO 08-07-2025
- Dividend Yield
- BHAT N/A
- APVO N/A
- EPS Growth
- BHAT N/A
- APVO N/A
- EPS
- BHAT N/A
- APVO N/A
- Revenue
- BHAT $18,724,190.00
- APVO N/A
- Revenue This Year
- BHAT N/A
- APVO N/A
- Revenue Next Year
- BHAT N/A
- APVO N/A
- P/E Ratio
- BHAT N/A
- APVO N/A
- Revenue Growth
- BHAT N/A
- APVO N/A
- 52 Week Low
- BHAT $1.61
- APVO $2.81
- 52 Week High
- BHAT $106.00
- APVO $485.37
- Technical
- Relative Strength Index (RSI)
- BHAT 51.92
- APVO 34.83
- Support Level
- BHAT $1.62
- APVO $2.89
- Resistance Level
- BHAT $1.80
- APVO $3.20
- Average True Range (ATR)
- BHAT 0.10
- APVO 0.27
- MACD
- BHAT 0.01
- APVO 0.24
- Stochastic Oscillator
- BHAT 63.00
- APVO 10.63
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.